three-month
Ascendis Hormone Replacement Therapy Faces Setback with FDA Review Extension
Ascendis Pharma, hormone replacement therapy, FDA review, delay, three-month extension.
Actionable Insights Powered by AI
Ascendis Pharma, hormone replacement therapy, FDA review, delay, three-month extension.